CCAT2 and non-small cell lung carcinoma: Also, Qiu et al. have demonstrated that CCAT2 together with serum tumour biomarker carcino-embryonic antigen can significantly increased predictive efficiency, and the combination could predict lymph node metastasis in NSCLC.